Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Emmanuelle Fantino
Senior Research Scientist
Research Interests
Explore related searches
Articles (4)
Year:
2026
Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion transporter required for epithelial homeostasis in the lung and other organs, with CFTR mutations leading to the autosomal recessive genetic disease CF. Apart from excessive mucus accumulation and dysregulated inflammation in the airways, people with CF (pwCF) exhibit defective innate immune responses and are susceptible to bacterial respiratory pathogens such as Pseudomonas aeruginosa . Here, we investigated the role of CFTR in macrophage antimicrobial responses, including the zinc toxicity response that is used by these innate immune cells against intracellular bacteria. Using both pharmacological approaches, as well as cells derived from pwCF, we show that CFTR is required for uptake and clearance of pathogenic Escherichia coli by CSF-1-derived primary human macrophages. CFTR was also required for E. coli -induced zinc accumulation and zinc vesicle formation in these cells, and E . coli residing in macrophages exhibited reduced zinc stress in the absence of CFTR function. Accordingly, CFTR was essential for reducing the intramacrophage survival of a zinc-sensitive E. coli mutant compared to wild-type E. coli . Ectopic expression of the zinc transporter SLC30A1 or treatment with exogenous zinc was sufficient to restore antimicrobial responses against E . coli in human macrophages. Zinc supplementation also restored bacterial killing in GM-CSF-derived primary human macrophages responding to P. aeruginosa , used as an in vitro macrophage model relevant to CF. Thus, restoration of the zinc toxicity response could be pursued as a therapeutic strategy to restore innate immune function and effective host defense in pwCF.
Year:
2024
Year:
2024
Year:
2023
Collaborators (7)
Matthew J. Sweet
Group Leader
University of Queensland
Scott Bell
Chair of Research
Griffith University
Peter Sly
University of Queensland
LUAN VU
Assistant Professor
University of Texas at San Antonio
Stephania Cormier
Wiener Professor
Louisiana State University
Paul Robinson
Research Leader
Woolcock Institute of Medical Research
Mark Schembri
Professor of Microbiology
University of Queensland
Make your next move.
Prepare your application
Review drafts before you send them.